A detailed history of Driehaus Capital Management LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Driehaus Capital Management LLC holds 352,021 shares of PRCT stock, worth $32.9 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
352,021
Previous 349,394 0.75%
Holding current value
$32.9 Million
Previous $21.3 Million 32.12%
% of portfolio
0.28%
Previous 0.23%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.31 - $84.99 $147,926 - $223,268
2,627 Added 0.75%
352,021 $28.2 Million
Q2 2024

Aug 14, 2024

BUY
$45.73 - $69.19 $3.29 Million - $4.98 Million
71,930 Added 25.92%
349,394 $21.3 Million
Q1 2024

May 15, 2024

SELL
$40.38 - $50.75 $3.76 Million - $4.72 Million
-93,065 Reduced 25.12%
277,464 $13.7 Million
Q4 2023

Feb 14, 2024

BUY
$24.89 - $43.41 $3.24 Million - $5.65 Million
130,199 Added 54.18%
370,529 $15.5 Million
Q3 2023

Nov 14, 2023

SELL
$30.02 - $38.81 $16,030 - $20,724
-534 Reduced 0.22%
240,330 $7.89 Million
Q2 2023

Aug 14, 2023

SELL
$26.7 - $37.02 $17.1 Million - $23.7 Million
-640,617 Reduced 72.68%
240,864 $8.51 Million
Q1 2023

May 15, 2023

SELL
$26.64 - $39.74 $109,463 - $163,291
-4,109 Reduced 0.46%
881,481 $25 Million
Q4 2022

Feb 14, 2023

BUY
$38.78 - $46.78 $570,686 - $688,414
14,716 Added 1.69%
885,590 $36.8 Million
Q3 2022

Nov 14, 2022

BUY
$30.9 - $50.65 $3.34 Million - $5.47 Million
107,989 Added 14.16%
870,874 $36.1 Million
Q2 2022

Aug 15, 2022

BUY
$29.23 - $44.45 $17 Million - $25.9 Million
582,789 Added 323.6%
762,885 $24.9 Million
Q1 2022

May 16, 2022

BUY
$16.89 - $35.74 $3.04 Million - $6.44 Million
180,096 New
180,096 $6.3 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.17B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.